AUSSENWIRTSCHAFT AUSTRIA

International Health Day 2026

24–25 Mar 2026 | Vienna, Austria

HomeAgendaSpeakerMarketplaceContactEEN Support Offices
Register
Register
Register

arterioscope FlexCo

Medtech company

www.arterioscope.comGraz, Austria
4 profile visits

About

arterioscope is a spin-off from Graz University of Technology and a deep-tech software company building an AI-powered digital biomarker platform for cardiovascular disease. We develop and validate machine-learning models that extract clinically relevant cardiac biomarkers and risk signals from ECG and PPG data, enabling scalable, non-invasive cardiovascular phenotyping.

Our technology is designed to support biotech and pharma companies in clinical research by generating robust, biomarker-grade cardiovascular insights from standard biosignals, without requiring dedicated hardware or hospital infrastructure. The platform is modular, device-agnostic, and protected by granted and pending patents in Europe and the United States.

arterioscope is currently preparing market entry and regulatory certification while raising its seed round to advance clinical validation and commercialization.

Let’s talk.

Business Areas

Biology/BiotechnologyPharmaceuticalsE-HealthDiagnosticsMedical TechnologyBiotech

Healthcare Data

Clinical TrialsTelemedicine

Representatives

Hermann Moser

Co-Founder & CEO

arterioscope FlexCo

Marketplace (2)

  • Investment

    Seed Investment in arterioscope

    arterioscope FlexCo is a spin-off from Graz University of Technology and currently raising its seed round.

    • E-Health
    • Diagnostics
    • Pharmaceuticals
    • Seed and Development
    • Biology/Biotechnology
    Author

    Hermann Moser

    Co-Founder & CEO at arterioscope FlexCo

    Graz, Austria